한글목차

소아용 백신 동향과 예측

세계 소아용 백신 시장은 2024년부터 2030년까지 5.7%의 CAGR을 기록하며 2030년에는 약 308억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 보호자와 의료진 사이에서 이러한 백신의 이점에 대한 인식이 높아지고, 혼합 백신에 대한 수요가 증가하고 있으며, 새롭고 혁신적인 소아용 백신이 지속적으로 개발되고 있다는 점입니다. 세계 소아용 백신 시장의 미래는 감염성 질환, 암, 알레르기, 폐렴구균성 질환, 독감, 홍역, 유행성이하선염, 풍진(MMR) 등 다양한 분야에서 기회가 있을 것으로 예상됩니다.

소아용 백신 시장 인사이트

Lucintel의 예측에 따르면, 폐렴구균 및 수막구균성 질환에서 결합형이 이들 바이러스에 대한 억제력을 제공하기 위해 많이 사용되기 때문에 예측 기간 동안 가장 높은 성장을 보일 것으로 예상했습니다.

북미 지역은 탄탄한 의료 인프라, 예방접종 프로그램에 대한 정부의 적극적인 노력, 소아 인구 증가로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

시장 규모 및 추정치: 소아용 백신의 시장 규모를 금액(억 달러)으로 추정.

동향 및 예측 분석: 각 부문별, 지역별 시장 동향(2018-2023년) 및 예측(2024-2030년)을 분석합니다.

세분화 분석: 백신 유형별, 기술별, 용도별, 지역별 소아용 백신 시장 규모(금액($B) 기준).

지역별 분석: 북미, 유럽, 아시아태평양, 기타 지역의 소아용 백신 시장 분석.

성장 기회: 소아용 백신의 종류, 기술, 용도, 지역별 성장 기회 분석.

전략 분석: 소아용 백신 시장의 M&A, 신제품 개발, 경쟁 상황 등.

Porter's Five Forces 모델을 기반으로 한 산업 경쟁 강도 분석.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 소아용 백신 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 소아용 백신 시장 동향(2018-2023년)과 예측(2024-2030년)
• 백신 유형별 세계 소아용 백신 시장
  • 1가
  • 다가
• 기술별 세계의 소아용 백신 시장
  • 약독성
  • 불활화
  • 서브유닛
  • 톡소이드
  • 공역
  • 기타
• 용도별 세계 소아용 백신 시장
  • 감염증
  • 암
  • 알레르기
  • 폐렴구균 질환
  • 인플루엔자
  • 홍역, 볼거리, 풍진(MMR)
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 소아용 백신 시장
• 북미의 소아용 백신 시장
• 유럽의 소아용 백신 시장
• 아시아태평양의 소아용 백신 시장
• 기타 지역의 소아용 백신 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 백신 유형별 세계 소아용 백신 시장 성장 기회
  • 기술별 세계의 소아용 백신 시장 성장 기회
  • 용도별 세계 소아용 백신 시장 성장 기회
  • 지역별 세계의 소아용 백신 시장 성장 기회
• 세계의 소아용 백신 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 소아용 백신 시장 능력 확대
  • 세계의 소아용 백신 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• GlaxoSmithKline
• Merck & Co
• Sanofi
• Pfizer
• Johnson & Johnson
• Bharat Biotech International
• Serum Institute of India

영문목차

Pediatric Vaccine Trends and Forecast

The future of the global pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications. The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

A more than 150-page report is developed to help in your business decisions.

Pediatric Vaccine by Segment

The study includes a forecast for the global pediatric vaccine by vaccine type, technology, application, and region.

Pediatric Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent
• Multivalent

Pediatric Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Pediatric Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Infectious Disease
• Cancer
• Allergy
• Pneumococcal Disease
• Influenza
• Measles, Mumps, and Rubella (Mmr)
• Others

Pediatric Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Pediatric Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pediatric vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pediatric vaccine companies profiled in this report include-

• Glaxosmithkline
• Merck & Co
• Sanofi
• Pfizer
• Johnson & Johnson
• Bharat Biotech International
• Serum Institute Of India

Pediatric Vaccine Market Insights

Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Features of the Global Pediatric Vaccine Market

Market Size Estimates: Pediatric vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pediatric vaccine market size by vaccine type, technology, application, and region in terms of value ($B).

Regional Analysis: Pediatric vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, applications, and regions for the pediatric vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pediatric vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pediatric vaccine market size?

Answer: The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030.

Q.2 What is the growth forecast for pediatric vaccine market?

Answer: The global pediatric vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pediatric vaccine market?

Answer: The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

Q4. What are the major segments for pediatric vaccine market?

Answer: The future of the pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications.

Q5. Who are the key pediatric vaccine market companies?

Answer: Some of the key pediatric vaccine companies are as follows:

• Glaxosmithkline
• Merck & Co
• Sanofi
• Pfizer
• Johnson & Johnson
• Bharat Biotech International
• Serum Institute Of India

Q6. Which pediatric vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

Q7. In pediatric vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pediatric vaccine market by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pediatric Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Pediatric Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Pediatric Vaccine Market by Vaccine Type
  • 3.3.1: Monovalent
  • 3.3.2: Multivalent
• 3.4: Global Pediatric Vaccine Market by Technology
  • 3.4.1: Live Attenuated
  • 3.4.2: Inactivated
  • 3.4.3: Subunit
  • 3.4.4: Toxoid
  • 3.4.5: Conjugate
  • 3.4.6: Others
• 3.5: Global Pediatric Vaccine Market by Application
  • 3.5.1: Infectious Disease
  • 3.5.2: Cancer
  • 3.5.3: Allergy
  • 3.5.4: Pneumococcal Disease
  • 3.5.5: Influenza
  • 3.5.6: Measles, Mumps, and Rubella (MMR)
  • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Pediatric Vaccine Market by Region
• 4.2: North American Pediatric Vaccine Market
  • 4.2.1: North American Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
  • 4.2.2: North American Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
• 4.3: European Pediatric Vaccine Market
  • 4.3.1: European Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
  • 4.3.2: European Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
• 4.4: APAC Pediatric Vaccine Market
  • 4.4.1: APAC Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
  • 4.4.2: APAC Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
• 4.5: ROW Pediatric Vaccine Market
  • 4.5.1: ROW Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
  • 4.5.2: ROW Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pediatric Vaccine Market by Vaccine Type
  • 6.1.2: Growth Opportunities for the Global Pediatric Vaccine Market by Technology
  • 6.1.3: Growth Opportunities for the Global Pediatric Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Pediatric Vaccine Market by Region
• 6.2: Emerging Trends in the Global Pediatric Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pediatric Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pediatric Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GlaxoSmithKline
• 7.2: Merck & Co
• 7.3: Sanofi
• 7.4: Pfizer
• 7.5: Johnson & Johnson
• 7.6: Bharat Biotech International
• 7.7: Serum Institute of India